Vestnik dermatologii i venerologiiVestnik dermatologii i venerologii0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov35710.25208/0042-4609-2017-93-6-86-90Pyoderma Faciale — from Clinical PracticeGorbunovJu. G.<p><span>PhD (Medicine), Associate Professor, Research Assistant, Department of Skin and Venereal Diseases</span></p>fake@neicon.ruChepushtanovaK. O.<p><span>MD, Attending Physician, Department of Skin and Venereal Diseases</span></p>kseniyachepushtanova@mail.ruRubinsS.<p><span>D.Sci. (Medicine), Associate Professor, Department of Dermatovenereology, Faculty of Medicine</span></p>fake@neicon.ruSamcovA. V.<p><span>D.Sci. (Medicine), Prof., Head of the Department of Skin and Venereal Diseases</span></p>fake@neicon.ruMilitary Medical Academy of S. M. Kirov, Ministry of Defense of the Russian FederationUniversity of Latvia2912201793686900202201802022018Copyright © 2017, Gorbunov J.G., Chepushtanova K.O., Rubins S., Samcov A.V.2017This article considers the clinical observation of the patient with rare and severe form of dermatosis — pyoderma faciale. The effectiveness of systemic corticosteroids with the gradual addition of the oral isotretinoin has been shown. Data on clinical features of this atypical form is provided.pyoderma facialesystem corticosteroidsisotretinoinpyoderma facialeсистемные глюкокортикостероидыизотретиноин[1. O’Leary P. A., Kierland R. R. Pyoderma Faciale. Arch. Dermatol. Syphilol. 1940;41:451–462.][2. Plewig G., Jansen T., Kligman A. M. Pyoderma Faciale: a Review and Report of 20 Additional Cases: is it Rosacea? Arch. Dermatol. 1992;128(12):1611–1617.][3. Самцов А. В. Акне и акнеформные дерматозы. М.: Фармтек, 2014. C. 235. [Samtsov A. V. Acne and Acneiform Dermatoses. M.: Farmtec, 2014. P. 235.]][4. Joshua A., Zeicher M. D. Acneiform Eruptions in Dermatology — Differential Diagnosis. Springer, 2014. Р. 43–44.][5. Grawford G. H., Pelle M. T., James W. D. Rosacea: I. Etiology, Pathogenesis and Subtype Classification. J. Am. Acad. Dermatol. 2004;51(3):327–341.][6. Cunliffe W. J., Gollnick H. P. M. Acne: Diagnosis and Management. CRC Press,, 2001. P. 94.][7. Kim T. G., Noh S. M., Do J. E. et al. Rosacea Fulminans with Ocular Involvement. Br. J. Dermatol. 2010;163(4):877–879.][8. Massa M. C., Su W. P. Pyoderma Faciale: A Clinical Study of Twenty-Nine Patients. J. Am. Acad. Dermatol. 1982;6(1):84–91.][9. Firooz A., Firoozabadi M. R., Dowlati Y. Rosacea Fulminans (Pyoderma Faciale): Successful Treatment of a 3 Year-Old Girl with Oral Isotretinoin. Br. J. Dermatol. 2001;40(3):203–205.][10. Rosen T., Unkefer R. P. Treatment of Pyoderma Faciale with Isotretinoin in a Patient with Ulcerative Colitis. Cutis. 1999;64(2):107–109.][11. Jansen T., Plewig G., Kingman A. M. Diagnosis and Treatment of Rosacea Fulminans. Dermatology. 1994;188(4):251–254.][12. Selder S. Pyoderma Faciale. J. Am. Acad. Dermatol. 2005;53(6):1104–1105.][13. Plewig G., Jansen J. The Rosacea. In: Fitzpatrick’s Dermatology in General Medicine. 5th ed. 1999. P. 785–799.][14. Dreno B., Layton A., Zouboulis C. C. et al. Adult Female Acne: a New Paradigm. J. Eur. Acad. Dermatol. Venereol. 2013;27(9):1063–1070.][15. Wilkin J., Dahl M., Detmar M. et. al. Standard Classification of Rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J. Am. Acad. Dermatol. 2002;46(4):584–587.]